Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 431-432

  Tsuboi, Isami ^a   Ida, Hirohisa ^a   Yoshikawa, Eiji ^a   Hiyoshi, Suehiro ^a   Yamaji, Emiko ^b   Nakayama, Issei ^b   Nonomiya, Tomoko ^c   Shigenobu, Fritz ^c   Shimizu, Masaki ^c   O'Hara, Koji ^c   Sawai, Tetsuo ^c   Mizuoka, Keiji ^a  

^a BML   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFDINIR; CEFDITOREN; CEFMETAZOLE; CEFOTIAM; CEFPODOXIME; CEFTAZIDIME; CEFTERAM; CIPROFLOXACIN; DIBEKACIN; FLOMOXEF; FOSFOMYCIN; HABEKACIN; KANAMYCIN; LEVOFLOXACIN; MINOCYCLINE; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; SULPERAZON; TOSUFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; ESCHERICHIA COLI O157; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DIARRHEA; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS;

EID: 0031918576     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Centers for Disease Control. 1993. Update: multistate outbreak of Escherichia coli O157:H7 infections from hamburgers - western United States, 1992-1993. Morbid. Mortal. Weekly Rep. 42:258-263.
2. Domagk, G. F., and R. Chilla. 1975. Glucose-6-phosphate dehydrogenase from Candida utilis. Methods Enzymol. 41:205-208.
3. Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
4. Japan Medical Journal. 1996. Treatment manual for Escherichia coli O157 infectious disease. Jpn. Med. J. 3772:92-93. (In Japanese.)
5. Japan Society of Chemotherapy. 1990. Method of MIC determination by broth microdilution method. Chemotherapy (Tokyo) 38:102-105. (In Japanese.)
6. Johnson, W. M., H. Lior, and G. S. Benzanson. 1983. Cytotoxic Escherichia coli O157:H7 associated with hemorrhagic colitis in Canada. Lancet i:76.
7. Kahan, F. M., J. S. Kahan, P. J. Cassidy, and H. Kroop. 1974. The mechanism of action of fosfomycin (phosphonomycin). Ann. N. Y. Acad. Sci. 235: 364-386.
8. Kanda, T., T. Nishina, and M. Iwata. 1995. Isolation of verocytotoxin-producing Escherichia coli from cattle feces. J. Jpn. Vet. Med. Assoc. 48: 978-980.
9. Kim, D. H., W. J. Lees, K. E. Kempsell, W. S. Lane, K. Duncan, and C. T. Walsh. 1996. Characterization of a Cys 115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry 35:4923-4928.
10. Kosuke, J. 1991. Hemorrhagic colitis caused by Escherichia coli O157:H7 infections in a kindergarten in Saitama. Clin. Microbiol. 18:457-465. (In Japanese.)
11. Lane, W. M., and K. C. Alexander. 1990. Hemolytic-uremic syndrome in children. Prostgraduate Med. 88:135-140.
12. O'Hara, K. 1993. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microbiol. Lett. 14:9-16.
13. Riley, L. W. 1987. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu. Rev. Microbiol. 41:383-407.